Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Refractory Septic Shock due to Acute Cholangitis Successfully Treated with Polymyxin B Hemoperfusion: A Case Report

Yasuhiro Ohtsuka and Shin Tsuchiya

A 76-year-old man was transferred to our department because of high fever with chills. According to the Tokyo Guidelines 2018, he was diagnosed with sepsis due to Grade III (severe) acute cholangitis. Fluid resuscitation, noradrenaline administration, antibiotic therapy, and an emergency endoscopic retrograde biliary drainage were
performed. Due to these treatments, his general condition improved initially; however, on the 5th hospital day, he eventually became persistently hypotensive despite adequate fluid resuscitation while on a vasopressor. Under the diagnosis of septic shock, intensive care including endotracheal intubation followed by mechanical ventilation, thoracic drainage, administration of vasopressors, strict antibiotic therapy, and total parenteral nutrition, was promptly initiated; however, he remained in shock. We judged his condition as refractory septic shock that was resistant to conventional treatments. Therefore, endotoxin adsorption therapy with polymyxin B hemoperfusion (PMX-DHP) was attempted on the 7th hospital day, and two sessions of PMX-DHP were carried out 24 h apart. Following this procedure, he successfully recovered from septic shock, and was discharged on the 84th hospital day.
We propose that PMX-DHP might be considered for the treatment of refractory septic shock due to acute cholangitis that is resistant to appropriate conventional treatments, especially when the presence of endotoxemia has been confirmed.